Sep 27, 2017 05:32 am UTC| Business
Generally well-tolerated with no clinically relevant safety signals in Phase 1 study At the highest dose level, 5 out of 6 patients (83%) reached an improvement of at least 50% in atopic dermatitis symptoms (EASI-50) by...
Sep 27, 2017 05:06 am UTC| Business
WISeKey International Holding (WIHN) Intends to Acquire Additional WISeKey SA Shares From Minority Shareholders Possible Change in Class A Share Ownership ZUG, Switzerland - September 27, 2017 - WISeKey...
WISeKey Announces Reorganization of its Management Team
Sep 27, 2017 05:02 am UTC| Business
WISeKey Announces Reorganization of its Management Team ZUG, Switzerland - September 27, 2017 - WISeKey International Holding Ltd ("WISeKey") (SIX: WIHN), a provider of Cybersecurity and IoT solutions, today...
Diet Doc’s Prescription Craving Control II Addresses Link Between Stress and Weight Gain
Sep 27, 2017 05:00 am UTC| Business
Lafayette, LA, Sept. 27, 2017 -- Actress Gabourey Sidibe (often referred to as her 2009 character, Precious) has undergone an impressive 140-pound weight loss initiated with a common underlying cause of weight gain,...
Ascendis Pharma A/S Announces Pricing of Public Offering of ADSs
Sep 27, 2017 04:16 am UTC| Business
COPENHAGEN, Denmark, Sept. 27, 2017 -- Ascendis Pharma A/S (Nasdaq:ASND), a clinical stage biopharmaceutical company, today announced the pricing of its underwritten public offering of 3,800,000 American Depositary...
Sep 27, 2017 02:50 am UTC| Business
NEW ORLEANS, Sept. 26, 2017 -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 2, 2017 to file lead plaintiff applications in a securities class action lawsuit against...
Sep 27, 2017 02:36 am UTC| Business
NEW YORK, Sept. 26, 2017 -- Strata Data Conference -- Zoomdata, developers of the world's fastest visual analytics platform for Big Data, stormed into the Strata Data Conference today in a big way, being showcased in...